Cosmo Pharmaceuticals N.V.

SWX:COPN Rapporto sulle azioni

Cap. di mercato: CHF 1.2b

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Cosmo Pharmaceuticals Gestione

Gestione criteri di controllo 1/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Giovanni Di Napoli

Amministratore delegato

n/a

Compenso totale

Percentuale dello stipendio del CEOn/a
Mandato del CEOless than a year
Proprietà del CEOn/a
Durata media del management3.7yrs
Durata media del Consiglio di amministrazioneless than a year

Aggiornamenti recenti sulla gestione

Recent updates

Market Participants Recognise Cosmo Pharmaceuticals N.V.'s (VTX:COPN) Revenues

May 02
Market Participants Recognise Cosmo Pharmaceuticals N.V.'s (VTX:COPN) Revenues

Cosmo Pharmaceuticals' (VTX:COPN) Weak Earnings May Only Reveal A Part Of The Whole Picture

Mar 28
Cosmo Pharmaceuticals' (VTX:COPN) Weak Earnings May Only Reveal A Part Of The Whole Picture

Broker Revenue Forecasts For Cosmo Pharmaceuticals N.V. (VTX:COPN) Are Surging Higher

Mar 26
Broker Revenue Forecasts For Cosmo Pharmaceuticals N.V. (VTX:COPN) Are Surging Higher

Cosmo Pharmaceuticals N.V.'s (VTX:COPN) Popularity With Investors Is Clear

Dec 01
Cosmo Pharmaceuticals N.V.'s (VTX:COPN) Popularity With Investors Is Clear

Earnings Beat: Cosmo Pharmaceuticals N.V. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Jul 29
Earnings Beat: Cosmo Pharmaceuticals N.V. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

We Think Cosmo Pharmaceuticals (VTX:COPN) Can Stay On Top Of Its Debt

Nov 24
We Think Cosmo Pharmaceuticals (VTX:COPN) Can Stay On Top Of Its Debt

Cosmo Pharmaceuticals' (VTX:COPN) Solid Profits Have Weak Fundamentals

Mar 31
Cosmo Pharmaceuticals' (VTX:COPN) Solid Profits Have Weak Fundamentals

These 4 Measures Indicate That Cosmo Pharmaceuticals (VTX:COPN) Is Using Debt Reasonably Well

Aug 02
These 4 Measures Indicate That Cosmo Pharmaceuticals (VTX:COPN) Is Using Debt Reasonably Well

Increases to CEO Compensation Might Be Put On Hold For Now at Cosmo Pharmaceuticals N.V. (VTX:COPN)

May 20
Increases to CEO Compensation Might Be Put On Hold For Now at Cosmo Pharmaceuticals N.V. (VTX:COPN)

Cosmo Pharmaceuticals (VTX:COPN) Seems To Use Debt Quite Sensibly

Apr 03
Cosmo Pharmaceuticals (VTX:COPN) Seems To Use Debt Quite Sensibly

When Can We Expect A Profit From Cosmo Pharmaceuticals N.V. (VTX:COPN)?

Mar 07
When Can We Expect A Profit From Cosmo Pharmaceuticals N.V. (VTX:COPN)?

AMMINISTRATORE DELEGATO

Giovanni Di Napoli (50 yo)

less than a year

Mandato

Mr. Giovanni Di Napoli is Chief Executive Officer and Director of Cosmo Pharmaceuticals N.V. from May 24, 2024. He was President of Gastrointestinal at Medtronic plc. He is an accomplished leader with an e...

Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Alessandro Della Cha
Executive Chairman18.7yrs€1.16mNessun dato
Niall Donnelly
Executive Director & CFO8.3yrsNessun datoNessun dato
Giovanni Di Napoli
Chief Executive Officer & Directorless than a yearNessun datoNessun dato
Mauro Ajani
Founder & Non-Executive Director18.7yrs€400.00kNessun dato
Marco Lecchi
Chief Operating Officer3.7yrsNessun datoNessun dato
Davide Malavasi
Qualified Person & Technical Director13yrsNessun datoNessun dato
Luigi Longo
Chief Scientific Officer2.4yrsNessun datoNessun dato
Hazel Winchester
Head of Investor Relations2.7yrsNessun datoNessun dato
Biagio Vigano
Chief People Officer3.7yrsNessun datoNessun dato
Roberto Villa
Chief Manufacturing Officer27.7yrsNessun datoNessun dato
Ngo Nhan
President of Cosmo Intelligent Medical Devicesno dataNessun datoNessun dato
Andrea Cherubini
SVP of Science4.7yrsNessun datoNessun dato

3.7yrs

Durata media

51.5yo

Età media

Gestione esperta: Il team dirigenziale di COPN è considerato esperto (durata media dell'incarico 3.6 anni).

Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Alessandro Della Cha
Executive Chairman18.7yrs€1.16mNessun dato
Niall Donnelly
Executive Director & CFOless than a yearNessun datoNessun dato
Giovanni Di Napoli
Chief Executive Officer & Directorless than a yearNessun datoNessun dato
Mauro Ajani
Founder & Non-Executive Director18.7yrs€400.00kNessun dato
William Sandborn
Member of Scientific Advisory Boardno dataNessun datoNessun dato
Geert D'Haens
Member of Scientific Advisory Boardno dataNessun datoNessun dato
Silvio Danese
Member of Scientific Advisory Boardno dataNessun datoNessun dato
Maria Roncarolo
Non-Executive Director12.4yrs€128.79kNessun dato
Ralf Kiesslich
Member of Scientific Advisory Boardno dataNessun datoNessun dato
Robert Steffen
Member of Scientific Advisory Boardno dataNessun datoNessun dato
Silvana Perretta
Non-Executive Directorless than a yearNessun datoNessun dato
John O'Dea
Non-Executive Directorless than a yearNessun datoNessun dato

0.3yrs

Durata media

61yo

Età media

Consiglio di amministrazione esperto: Il consiglio di amministrazione di COPN non è considerato esperto (durata media del mandato 0.3 anni), il che suggerisce un nuovo consiglio.